Cargando…
RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Turkish Society of Gastroenterology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152175/ https://www.ncbi.nlm.nih.gov/pubmed/36919837 http://dx.doi.org/10.5152/tjg.2023.237002 |
| _version_ | 1785035697895243776 |
|---|---|
| author | Ergenç, İlkay Tarık Kani, Haluk Karabacak, Murat Cömert Özer, Elif Mehdiyev, Shahin Jafarov, Fuad Yiğit Abacar, Kerem Kutluğ Ağaçkıran, Seda Sevik, Gizem Aslan, Rahmi Alibaz Öner, Fatma İnanç, Nevsun Pamir Atagündüz, Mehmet Seçkin, Dilek Özen Alahdab, Yeşim Ergun, Tülin Direskeneli, Haner Atuğ, Özlen |
| author_facet | Ergenç, İlkay Tarık Kani, Haluk Karabacak, Murat Cömert Özer, Elif Mehdiyev, Shahin Jafarov, Fuad Yiğit Abacar, Kerem Kutluğ Ağaçkıran, Seda Sevik, Gizem Aslan, Rahmi Alibaz Öner, Fatma İnanç, Nevsun Pamir Atagündüz, Mehmet Seçkin, Dilek Özen Alahdab, Yeşim Ergun, Tülin Direskeneli, Haner Atuğ, Özlen |
| author_sort | Ergenç, İlkay |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10152175 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Turkish Society of Gastroenterology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101521752023-05-03 RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy Ergenç, İlkay Tarık Kani, Haluk Karabacak, Murat Cömert Özer, Elif Mehdiyev, Shahin Jafarov, Fuad Yiğit Abacar, Kerem Kutluğ Ağaçkıran, Seda Sevik, Gizem Aslan, Rahmi Alibaz Öner, Fatma İnanç, Nevsun Pamir Atagündüz, Mehmet Seçkin, Dilek Özen Alahdab, Yeşim Ergun, Tülin Direskeneli, Haner Atuğ, Özlen Turk J Gastroenterol Author’s Reply Turkish Society of Gastroenterology 2023-03-01 /pmc/articles/PMC10152175/ /pubmed/36919837 http://dx.doi.org/10.5152/tjg.2023.237002 Text en 2023 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/) |
| spellingShingle | Author’s Reply Ergenç, İlkay Tarık Kani, Haluk Karabacak, Murat Cömert Özer, Elif Mehdiyev, Shahin Jafarov, Fuad Yiğit Abacar, Kerem Kutluğ Ağaçkıran, Seda Sevik, Gizem Aslan, Rahmi Alibaz Öner, Fatma İnanç, Nevsun Pamir Atagündüz, Mehmet Seçkin, Dilek Özen Alahdab, Yeşim Ergun, Tülin Direskeneli, Haner Atuğ, Özlen RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy |
| title | RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy |
| title_full | RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy |
| title_fullStr | RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy |
| title_full_unstemmed | RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy |
| title_short | RE: Risk of HBV Reactivation in HBsAg Negative and Anti-HBc IgG Positive Patients Receiving Biologic Therapy |
| title_sort | re: risk of hbv reactivation in hbsag negative and anti-hbc igg positive patients receiving biologic therapy |
| topic | Author’s Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152175/ https://www.ncbi.nlm.nih.gov/pubmed/36919837 http://dx.doi.org/10.5152/tjg.2023.237002 |
| work_keys_str_mv | AT ergencilkay reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT tarıkkanihaluk reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT karabacakmurat reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT comertozerelif reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT mehdiyevshahin reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT jafarovfuad reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT yigitabacarkerem reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT kutlugagackıranseda reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT sevikgizem reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT aslanrahmi reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT alibazonerfatma reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT inancnevsun reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT pamiratagunduzmehmet reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT seckindilek reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT ozenalahdabyesim reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT erguntulin reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT direskenelihaner reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy AT atugozlen reriskofhbvreactivationinhbsagnegativeandantihbciggpositivepatientsreceivingbiologictherapy |